Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ONCOLINER tumorized precision dataset

ABSTRACT: Tumorized precision dataset for ONCOLINER: A new solution for monitoring, improving, and harmonizing somatic variant calling across genomic oncology centers

PROVIDER: PRJEB68324 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	tumorized_HG002_GRCh37_GRCh37_60X_precision_T.cram.annotated.vcf	Other
	tumorized_NA12878_GRCh37_GRCh37_60X_precision_T.cram.annotated.vcf	Other
	ERR12264432_1.fastq.gz	Fastqsanger.gz
	ERR12264432_2.fastq.gz	Fastqsanger.gz
	ERR12261542_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

CPTAC: Microscaled Proteogenomic Methods for Precision Oncology

Project description:CPTAC: Microscaled Proteogenomic Methods for Precision Oncology

| PRJNA574688 | ENA

CPTAC: Microscaled Proteogenomic Methods for Precision Oncology

Project description:CPTAC: Microscaled Proteogenomic Methods for Precision Oncology

| PRJNA574689 | ENA

The OncoLoop Network-based Precision Oncology Framework

Project description:The OncoLoop Network-based Precision Oncology Framework

| PRJNA774549 | ENA

Patient-derived micro-organospheres (MOS) enable clinical precision oncology

Project description:Patient-derived xenografts (PDX) and organoids (PDO) have been shown to model clinical response to cancer therapy. However, it remains challenging to use these models to guide timely clinical decisions for cancer patients. Here we used droplet emulsion microfluidics with temperature control and dead-volume minimization to rapidly generate thousands of Micro- Organospheres (MOS) from low-volume patient tissues, which serve as an ideal patient-derived model for clinical precision oncology. A clinical study of newly diagnosed metastatic colorectal cancer (CRC) patients using a MOS-based precision oncology pipeline reliably predicted patient treatment outcome within 14 days, a timeline suitable for guiding treatment decisions in clinic. Furthermore, MOS capture original stromal cells and allow T cell penetration, providing a clinical assay for testing immuno-oncology (IO) therapies such as PD-1 blockade, bispecific antibodies, and T cell therapies on patient tumors.

2022-09-01 | GSE184242 | GEO

Functional precision medicine identifies new therapeutic candidates for medulloblastoma (expression dataset)

Project description:Functional precision medicine identifies new therapeutic candidates for medulloblastoma (expression dataset)

| PRJNA635573 | ENA

Functional precision medicine identifies new therapeutic candidates for medulloblastoma (methylation dataset)

Project description:Functional precision medicine identifies new therapeutic candidates for medulloblastoma (methylation dataset)

| PRJNA635574 | ENA

The Brazilian Initiative on Precision Medicine (BIPMed)

Project description:The development of precision medicine strategies requires prior knowledge of the genetic background of the target population. However, despite the availability of data from admixed Americans within large reference population databases, we cannot use these data as a surrogate for that of the Brazilian population. This lack of transferability is mainly due to differences between ancestry proportions of Brazilian and other admixed American populations. To address the issue, a coalition of research centres created the Brazilian Initiative on Precision Medicine (BIPMed), an initiative of five Research Innovation and Dissemination Centers (RIDCs) supported by FAPESP.

2020-08-22 | GSE156652 | GEO

Patient-derived micro-organospheres (MOS) enable clinical precision oncology

Project description:Patient-derived micro-organospheres (MOS) enable clinical precision oncology

| PRJNA763787 | ENA

Synthetic lethality-mediated precision oncology via the tumor transcriptome

Project description:Synthetic lethality-mediated precision oncology via the tumor transcriptome

| PRJNA700986 | ENA

Towards Optimization of Precision Oncology in Metastatic Uterine Tumors

Project description:Towards Optimization of Precision Oncology in Metastatic Uterine Tumors

| PRJNA887066 | ENA